CNBC Says Goodbye to More Viewers
Tweet
Share
E-mail
Despite another strong month for the stock market in October, leading business news network CNBC continues to struggle to hold onto viewers.
Data from Nielsen Media Research showed that the network is down 30% in their key 25-54 advertising demographic during the business day (5AM-7PM).
The data shows a precipitous decline in this key target market since May. In fact every month since that time been lower, expect August which was flat. At 76,000 last October in the target demo, this number has fallen to 53,000. It was at 54,000 in September.
With Comcast (Nasdaq: CMCSCA) soon taking over NBC Universal, executives will no doubt be taking a close look at CNBC to figure how they can stop the downward spiral.
The decline could suggest that investors are turning to rival networks including Bloomberg TV and Fox Business Network. In addition, stock related video content on the Internet has gotten better over the years with sites like TechTicker, WSJ.com and StockTwits.tv getting in on the action.
Data from Nielsen Media Research showed that the network is down 30% in their key 25-54 advertising demographic during the business day (5AM-7PM).
The data shows a precipitous decline in this key target market since May. In fact every month since that time been lower, expect August which was flat. At 76,000 last October in the target demo, this number has fallen to 53,000. It was at 54,000 in September.
With Comcast (Nasdaq: CMCSCA) soon taking over NBC Universal, executives will no doubt be taking a close look at CNBC to figure how they can stop the downward spiral.
The decline could suggest that investors are turning to rival networks including Bloomberg TV and Fox Business Network. In addition, stock related video content on the Internet has gotten better over the years with sites like TechTicker, WSJ.com and StockTwits.tv getting in on the action.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Airlines (LUV) Director Rakesh Gangwal Buys Nearly 1.9 Million Shares
- Ultragenyx Pharma (RARE) Provides Update on Stage 1 Cohorts in Phase 1/2/3 Cyprus2+ Study
- Citizens Financial Group (CFG) files mixed shelf
Create E-mail Alert Related Categories
Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
